Independent and cutting-edge analysis on global affairs
Turkey is at the vanguard of a global trend of implementing universal health coverage. Building on that leadership position, Prime Minister Erdoğan has set a goal for Turkey to become a global leader in the delivery of health services over the next decade. A key element of developing the health care market in Turkey is expanding the country’s biopharmaceutical sector. For Turkey to meet its health care objectives, it needs to maintain a public policy environment that ensures adequate resources for health care and fosters innovation and investment in the biopharmaceutical sector. Too often, the government’s short-term cost containment polices have conflicted with its aspirations for ensuring Turkish citizens have access to needed innovative therapies and growing a biopharmaceutical sector.
 
 
CONTRIBUTOR
Rod Hunter
Rod Hunter
This issue was published in collaboration with AmCham Turkey.
From the Desk of the Editor TPQ’s Winter 2019/20 issue, published in collaboration with AmCham Turkey, titled A Long-Lasting Affinity: Acknowledging US-Turkey Ties, lays out how strong cultural, educational, and professional relationships across different sectors culminate in beneficial partnerships and success stories. Our dedicated readers will realize that this Winter issue is a continuation of our new brand TPQ...
STAY CONNECTED
SIGN UP FOR NEWSLETTER
FACEBOOK
PARTNERS